CareDx Inc
NASDAQ:CDNA
CareDx Inc
Revenue
CareDx Inc
Revenue Peer Comparison
Competitive Revenue Analysis
Latest Figures & CAGR of Competitors
Company | Revenue | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
CareDx Inc
NASDAQ:CDNA
|
Revenue
$280.3m
|
CAGR 3-Years
13%
|
CAGR 5-Years
30%
|
CAGR 10-Years
29%
|
|
Abbvie Inc
NYSE:ABBV
|
Revenue
$54.3B
|
CAGR 3-Years
6%
|
CAGR 5-Years
11%
|
CAGR 10-Years
11%
|
|
Gilead Sciences Inc
NASDAQ:GILD
|
Revenue
$27.5B
|
CAGR 3-Years
2%
|
CAGR 5-Years
4%
|
CAGR 10-Years
7%
|
|
Amgen Inc
NASDAQ:AMGN
|
Revenue
$28.2B
|
CAGR 3-Years
4%
|
CAGR 5-Years
3%
|
CAGR 10-Years
4%
|
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
Revenue
$9.9B
|
CAGR 3-Years
17%
|
CAGR 5-Years
26%
|
CAGR 10-Years
23%
|
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
Revenue
$13.1B
|
CAGR 3-Years
16%
|
CAGR 5-Years
14%
|
CAGR 10-Years
20%
|
CareDx Inc
Revenue Breakdown
Breakdown by Geography
CareDx Inc
Total Revenue:
280.3m
USD
|
United States:
265.6m
USD
|
Europe:
10.2m
USD
|
Rest Of World:
4.5m
USD
|
Breakdown by Segments
CareDx Inc
Total Revenue:
280.3m
USD
|
Testing Services Revenue:
209.7m
USD
|
Patient And Digital Solutions:
37.1m
USD
|
Product Revenue:
33.5m
USD
|
See Also
What is CareDx Inc's Revenue?
Revenue
280.3m
USD
Based on the financial report for Dec 31, 2023, CareDx Inc's Revenue amounts to 280.3m USD.
What is CareDx Inc's Revenue growth rate?
Revenue CAGR 10Y
29%
Over the last year, the Revenue growth was -13%. The average annual Revenue growth rates for CareDx Inc have been 13% over the past three years , 30% over the past five years , and 29% over the past ten years .